Neonatal Thyrotoxicosis and Persistent Pulmonary Hypertension Necessitating Extracorporeal Life Support

PEDIATRICS ◽  
2005 ◽  
Vol 115 (1) ◽  
pp. e105-e108 ◽  
Author(s):  
Jon Oden ◽  
Ira M. Cheifetz
PEDIATRICS ◽  
1995 ◽  
Vol 96 (6) ◽  
pp. 1159-1161
Author(s):  
Bhaktharaj P. Chelliah ◽  
David Brown ◽  
Morris Cohen ◽  
Andre J. Talleyrand ◽  
Susan Shen-Schwarz

Recurrence of persistent pulmonary hypertension of the newborn (PPHN) after successful extracorporeal membrane oxygenation (ECMO) therapy has been reported.1,2 Payne1 treated the recurrence of PPHN with conventional therapy, and two of his three patients recovered. De La Cruz2 reported using a second course of ECMO to treat a recurrence of pulmonary hypertension and respiratory failure of other origins in three patients. Two of the three infants survived. As of January 13, 1993, there were a total of 47 infants reported to the Extracorporeal Life Support Organization (ELSO) who had undergone a second course of ECMO.3 The two most common diagnoses among these infants were congenital diaphragrnatic hernia and PPHN.


2016 ◽  
Vol 35 (4) ◽  
pp. S371-S372
Author(s):  
T. Kortchinsky ◽  
S. Mussot ◽  
S. Rezaiguia-Delclaux ◽  
M. Artiguenave ◽  
E. Fadel ◽  
...  

Neonatology ◽  
2021 ◽  
pp. 1-8
Author(s):  
Dalya Munves Ferguson ◽  
Vikas S. Gupta ◽  
Pamela A. Lally ◽  
Matias Luco ◽  
KuoJen Tsao ◽  
...  

<b><i>Introduction:</i></b> Pulmonary hypertension (PH) is the major pathophysiologic consequence of congenital diaphragmatic hernia (CDH). We aimed to evaluate the association between early CDH-associated PH (CDH-PH) and inpatient outcomes. <b><i>Methods:</i></b> The CDH Study Group registry was queried for infants born 2015–2019 with echocardiograms before 48h of life. PH was categorized using echocardiographic findings: none, mild (right ventricular systolic pressure &#x3c;2/3 systemic), moderate (between 2/3 systemic and systemic), or severe (supra-systemic). Univariate and multivariate analyses were performed. Adjusted Poisson regression was used to assess the primary composite outcome of mortality or oxygen support at 30 days. <b><i>Results:</i></b> Of 1,472 patients, 86.5% had CDH-PH: 13.9% mild (<i>n</i> = 193), 44.4% moderate (<i>n</i> = 631), and 33.2% severe (<i>n</i> = 468). On adjusted analysis, the primary outcome of mortality or oxygen support at 30 days occurred more frequently in infants with moderate (incidence rate ratio [IRR] 1.8, 95% confidence interval [CI], 1.2–2.6) and severe CDH-PH (IRR 2.0, 95% CI, 1.3–2.9). Extracorporeal life support (ECLS) utilization was associated only with severe CDH-PH after adjustment (IRR 1.8, 95% CI, 1.0–3.3). <b><i>Discussion/Conclusion:</i></b> Early, postnatal CDH-PH is independently associated with increased risk for mortality or oxygen support at 30 days and utilization of ECLS. Early echocardiogram is a valuable prognostic tool for early, inpatient outcomes in neonates with CDH.


2019 ◽  
Vol 8 (1) ◽  
pp. 84-92 ◽  
Author(s):  
Sofia Martin-Suarez ◽  
Gregorio Gliozzi ◽  
Mariafrancesca Fiorentino ◽  
Antonio Loforte ◽  
Valentina Ghigi ◽  
...  

2017 ◽  
Vol 26 (146) ◽  
pp. 170092 ◽  
Author(s):  
Laurent Savale ◽  
Jason Weatherald ◽  
Xavier Jaïs ◽  
Constance Vuillard ◽  
Athénaïs Boucly ◽  
...  

Acute right heart failure in chronic precapillary pulmonary hypertension is characterised by a rapidly progressive syndrome with systemic congestion resulting from impaired right ventricular filling and/or reduced right ventricular flow output. This clinical picture results from an imbalance between the afterload imposed on the right ventricle and its adaptation capacity. Acute decompensated pulmonary hypertension is associated with a very poor prognosis in the short term. Despite its major impact on survival, its optimal management remains very challenging for specialised centres, without specific recommendations. Identification of trigger factors, optimisation of fluid volume and pharmacological support to improve right ventricular function and perfusion pressure are the main therapeutic areas to consider in order to improve clinical condition. At the same time, specific management of pulmonary hypertension according to the aetiology is mandatory to reduce right ventricular afterload. Over the past decade, the development of extracorporeal life support in refractory right heart failure combined with urgent transplantation has probably contributed to a significant improvement in survival for selected patients. However, there remains a considerable need for further research in this field.


2016 ◽  
Vol 65 (9) ◽  
pp. 532-534 ◽  
Author(s):  
Ryosuke Hara ◽  
Shuhei Hara ◽  
Chin Siang Ong ◽  
Gary Schwartz ◽  
Christopher Sciortino ◽  
...  

ASAIO Journal ◽  
2020 ◽  
Vol 66 (9) ◽  
pp. 1063-1067
Author(s):  
Alejandra Pena Hernandez ◽  
Nicholas R. Carr ◽  
Donald McCurnin ◽  
Veronica Armijo-Garcia

2021 ◽  
pp. 1-2
Author(s):  
Lucie Genet ◽  
Daniele De Luca

Abstract Persistent pulmonary hypertension of the neonate can cause acute and life-threatening hypoxia, but preterm neonates are not suitable candidate to extra-corporeal life support. We report the unique case of an extremely preterm neonates with life-threatening persistent pulmonary hypertension refractory to triple vasodilator therapy (nitric oxide, iloprost, and bosentan), which has been successfully treated with the addition of adenosine continuous infusion.


Sign in / Sign up

Export Citation Format

Share Document